Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001074226-00-000056
Filing Date
2000-05-26
Accepted
2000-05-26 00:00:00
Documents
1
Group Members
I.G. INVESTMENT MANAGEMENT, LTD.INVESTORS GLOBAL SCIENCE & TECHNOLOGY FUNDINVESTORS GROUP INCINVESTORS GROUP INC.INVESTORS GROUP TRUST CO. LTD.INVESTORS GROUP TRUSTCO INC.INVESTORS SPECIAL FUNDINVESTORS SUMMA FUND

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G SC 13G 39694
  Complete submission text file 0001074226-00-000056.txt   42322
Mailing Address 2292 FARADAY AVE CARLSBAD CA 92008
Business Address 2292 FARADAY AVE CARLSBAD CA 92008 7609319200
ISIS PHARMACEUTICALS INC (Subject) CIK: 0000874015 (see all company filings)

EIN.: 330336973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-41771 | Film No.: 644505
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE CANADA CENTRE 447 PORTAGE AVENUE R3C 3B6 WINNIPEG MANITOBA A2
Business Address ONE CANADA CENTRE 447 PORTAGE AVENUE WINNIPEG MANITOBA WINNIPEG CANADA 2049568444
INVESTORS GROUP INC (Filed by) CIK: 0001074226 (see all company filings)

EIN.: 000000000 | State of Incorp.: A2 | Fiscal Year End: 1231